Explore how GLP-1 agonists like semaglutide treat PCOS and obesity by targeting insulin resistance and driving significant weight loss. Learn about benefits, side effects, and real-world outcomes.
Metabolic syndrome is a cluster of heart disease risk factors including abdominal obesity, high blood pressure, and insulin resistance. Learn how to identify it, why it's dangerous, and how lifestyle changes can reverse it.